NCT02544217View on ClinicalTrials.gov

A Dose-escalating Clinical Trial With KH176

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
MELASLHONLeigh SyndromeMitochondrial DiseaseMitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation
Interventions
DRUG

KH176

DRUG

placebo

Trial Locations (1)

Unknown

Drug Research Unit Ghent, Ghent

Sponsors

Lead Sponsor

Khondrion BV
All Listed Sponsors
collaborator

University Ghent

OTHER

lead

Khondrion BV

INDUSTRY